Search results for "PATIENT"

showing 10 items of 5265 documents

Optical analysis to predict outcomes after implantation of a double intraocular lens magnification device.

2007

Purpose To analyze the effect of different optical parameters of the eye on the outcomes of implantation of a double intraocular lens (IOL) magnification device in patients with low vision. Setting Fundacion Oftalmologica del Mediterraneo, Valencia, Spain. Methods The eye's refraction and magnification before and after surgery were evaluated using a theoretical eye model based on paraxial optics approximation. Four parameters on which refraction and magnification are dependent were evaluated: anterior chamber depth (ACD), axial length (AL), mean keratometry (Km), and the distance between the 2 implanted IOLs. The 4 variables were analyzed separately in the first stage. Next, different combi…

medicine.medical_specialtyOptics and PhotonicsBiometrygenetic structuresAnterior Chambermedicine.medical_treatmentMagnificationVision LowIntraocular lensEyeRefraction Ocularlaw.inventionOpticsLens Implantation IntraocularlawOphthalmologymedicineMyopiaHumansIn patientPhysicsLenses IntraocularKeratometerbusiness.industryParaxial approximationModels TheoreticalMagnification deviceRefractioneye diseasesSensory SystemsLow visionOphthalmologyHyperopiaTreatment OutcomeSurgerysense organsbusinessJournal of cataract and refractive surgery
researchProduct

Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure

2022

Introduction and objectives: Carbohydrate antigen 125 (CA125) has been shown to be useful for risk stratification in patients admitted with acute heart failure (AHF). We sought to determine a CA125 cutpoint for identifying patients at low risk of 1-month death or the composite of death/HF readmission following admission for AHF.Methods: The derivation cohort included 3231 consecutive patients with AHF. CA125 cutoff values with 90% negative predictive value (NPV) and sensitivity up to 85% were identified. The adequacy of these cutpoints and the risk of 1-month death/HF readmission was then tested using the Royston-Parmar method. The best cutpoint was selected and externally validated in a co…

medicine.medical_specialtyOptimal cutoffAntígeno carbohidrato 125MONOCLONAL-ANTIBODYendocrine system diseasesCarbohydratesAftercareInsuficiencia cardiaca aguda030204 cardiovascular system & hematologyWorsening Heart FailureCA12503 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansCutoffIn patientOutcomeHeart FailureNATRIURETIC PEPTIDEbusiness.industryMORTALITYPronósticoGeneral MedicineCongestiónPrognosismedicine.diseasePredictive valuePatient Dischargefemale genital diseases and pregnancy complicationsAntígeno carbohidrato 125; CA125; Carbohydrate antigen 125; Congestion; Congestión; Insuficiencia cardiaca aguda; Outcome; Pronóstico; Worsening Heart Failure; Acute Disease; CA-125 Antigen; Carbohydrates; Humans; Patient Discharge; Prognosis; Aftercare; Heart FailureCarbohydrate antigen 125CA-125 AntigenHeart failureAcute DiseaseCohortRisk stratificationCongestionbusinessCarbohydrate antigenRevista Española de Cardiología (English Edition)
researchProduct

Osteonecrosis of the jaws associated with denosumab : study of clinical and radiographic characteristics in a series of clinical cases

2020

Background The objective of this study was to describe the clinical and radiographic characteristics of our series of medication-related osteonecrosis of the jaws (ONJ) associated with denosumab. Material and methods We presented 15 cases of ONJ associated with denosumab; 11 received treatment for their osteoporosis and four for cancer treatments. We recorded the most frequent clinical findings, symptoms and radiographic characteristics in our patient group, as well as local and systemic contributing factors. Results The mean time of treatment with denosumab was 23.83 ± 12.84 months. 40% of the patients had a previous history of treatment with bisphosphonates. The most common local factor w…

medicine.medical_specialtyOral Medicine and PathologyOsteolysisbusiness.industryResearchRadiographyOsteoporosisCancer030206 dentistrymedicine.diseaseLocal factor:CIENCIAS MÉDICAS [UNESCO]03 medical and health sciences0302 clinical medicineDenosumab030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASmedicineRadiologyStage (cooking)Patient groupbusinessGeneral Dentistrymedicine.drug
researchProduct

Post endodontic Aspergillosis in an immunocompetent individual

2015

Non-invasive aspergillosis in immunocompetent individuals subsequent to post endodontic treatment can involve the maxillary antrum. An early and accurate diagnosis will aid in prompt and effective treatment. A 35 year old female patient reported with a painful nasomaxillary swelling. Previous records revealed the failure of the endodontic treatment of maxillary left second premolar which was subsequently extracted. Root piece was accidently left behind which resulted in a painful nasomaxillary swelling. The extraction socket was curetted and tissue was sent for histopathological examination, which revealed abundant septate fungal hyphae with numerous spores characteristic of Aspergillus. Th…

medicine.medical_specialtyOral Medicine and Pathologybusiness.industryItraconazoleCase ReportOdontologíamedicine.diseaseAspergillosis:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryFemale patientUNESCO::CIENCIAS MÉDICASmedicineEffective treatmentDifferential diagnosisbusinessGeneral DentistryMaxillary left second premolarAspergillomaSeptate fungal hyphaemedicine.drug
researchProduct

Dabigatran: A new oral anticoagulant. Guidelines to follow in oral surgery procedures. A systematic review of the literature.

2015

Background Dabigatran is a newly commercialized drug that is replacing other anticoagulants in the prevention of venous thromboembolism, stroke and systemic arterial valve embolism. It acts directly on thrombin presenting in a dynamic and predictable way, which does not require monitoring these patients. Therefore, we consider the need to assess whether their use increases the risk of bleeding involved before any dental treatment. Material and Methods We performed a systematic review with a bibliographic search in PubMed/Medline along with the Cochrane Library. We excluded articles dealing with all anticoagulants other than dabigatran, and works about surgical treatments in anatomical locat…

medicine.medical_specialtyOral Surgical ProceduresPsychological interventionMEDLINEAdministration OralReviewCochrane LibraryPostoperative Hemorrhagelaw.inventionDabigatran03 medical and health sciences0302 clinical medicineRandomized controlled triallawMedicineHumansIntensive care medicineGeneral DentistryStrokebusiness.industryAnticoagulants030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMedically compromised patients in DentistrySurgeryDabigatranClinical trialOtorhinolaryngologyEmbolism030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASSurgerybusinessmedicine.drugMedicina oral, patologia oral y cirugia bucal
researchProduct

Study of serum ctx in 50 oral surgical patients treated with oral bisphosphonates

2011

Objectives: To determine whether there is a relationship between the total BP dose administered and the variations in serum CTX concentration. Study design: The study included 50 patients requiring dental implant surgery and treated with oral BPs, seen in an Oral Surgery and Implantology Unit between January 2007 and June 2009. The patients were divided into two groups: those in which the medication was not suspended before obtaining the laboratory test sample, and those patients referred from other dental clinics in which BPs was suspended before reporting to our Unit. The total drug dosage administered and the total dose per kilogram body weight were evaluated for comparison with serum CT…

medicine.medical_specialtyOral bisphosphonatesOral Medicine and Pathologybusiness.industryOral surgeryOral Surgical ProceduresBody weight:CIENCIAS MÉDICAS [UNESCO]GastroenterologySurgeryDental implant surgeryLaboratory testOtorhinolaryngologyTotal doseInternal medicineUNESCO::CIENCIAS MÉDICASmedicineSurgeryResearch-ArticlebusinessGeneral DentistrySurgical patients
researchProduct

Oral manifestations of HIV/AIDS in Asia: Systematic review and future research guidelines

2015

Objectives: The authors have conducted a systematic review of oral manifestations of HIV from studies conducted in Asia to establish the characteristics and prevalence of individual oral manifestations in Asia, and to assess the direction of future research studies on oral manifestations of HIV in Asia. Material and Methods: The electronic retrieval systems and databases searched for relevant articles were PubMed [MEDLINE], EBSCO, and EMBASE. The search was for limited articles published in English or with an English abstract and articles published during the period January 1995 to August 2014. The authors reached a final overall sample of 39 studies that were conducted in Asia. Results: Th…

medicine.medical_specialtyOral hairy leukoplakiaOral Medicine and PathologyTraditional medicinebusiness.industryAlternative medicineMEDLINEOdontologíaReview:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludstomatognathic diseasesClinical researchAcquired immunodeficiency syndrome (AIDS)Family medicineUNESCO::CIENCIAS MÉDICASEpidemiologyHiv patientsmedicineResearch studiesbusinessGeneral DentistryJournal of Clinical and Experimental Dentistry
researchProduct

Non-muscle invasive bladder cancer: Are epicrises the ‘Bermuda Triangle’ of information transfer?

2017

Introduction The aim of the study was to collect information regarding the quality of communication of risk-determining factors or risk profile, and the guideline conformity of recommendations for adjuvant treatment in patients with non-muscle invasive bladder cancer (NMIBC) between clinical and ambulatory urologists. Material and methods At three German urological clinics during the period between 2012-2014, epicrises of 1,033 NMIBC-patients were retrospectively summarised to 505 tumour episodes (tumour resection including any re-resections) and analysed regarding the endpoints 1) risk profile is explicitly named or recorded risk factors are sufficient for the determination of risk profile…

medicine.medical_specialtyOriginal PaperProcess Assessment (Health Care)Bladder cancerbusiness.industryTumor resection030232 urology & nephrologyGuideline complianceGuideline adherenceGeneral MedicineGuidelinemedicine.diseaseLogistic regression03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisInternal medicineGermanyAmbulatorymedicineIn patientNon muscle invasivebusinessurinary bladder neoplasmsCentral European Journal of Urology
researchProduct

Implant treatment in patients with osteoporosis

2010

Osteoporosis is very common, particularly in post-menopausal women and is characterized by a decrease in bone mass and strength. Osteoporosis also affects the jawbone and it is considered a potential contraindication to placement of dental implants. The present paper reviews the literature regarding the effect of osteoporosis on osseointegration of implants. Experimental models have shown that osteoporosis affects the process of osseointegration, which can be reversed by treatment. However, studies in subjects with osteoporosis have shown no differences in survival of the implants compared to healthy individuals. Therefore, osteoporosis cannot be considered a contraindication for implant pl…

medicine.medical_specialtyOsteoporosisDentistryOsseointegrationOsseointegrationInformed consentHumansMedicineIn patientGeneral DentistryContraindicationDental ImplantsDiphosphonatesbusiness.industrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryOtorhinolaryngologyPractice Guidelines as TopicUNESCO::CIENCIAS MÉDICASOsteoporosisSurgeryImplantbusinessOsteonecrosis of the jawComplicationJaw Diseases
researchProduct

Alendronate-associated osteonecrosis of the jaws: a review of the main topics

2013

Bisphosphonates is a group of inorganic pyrophosphates analogues that suppress bone resorption by inducing osteoclast inactivation, being frequently used for management of diseases affecting bone metabolism, bone metastases and bone tumors. However, since 2003 many cases describing the presence of necrotic bone exposures in the jaws have been described in patients receiving these drugs, what represent a significant complication of bisphosphonates treatment. The overall incidence of bisphosphonate-related osteonecrosis of the jaws is low, ranging from 0.7% to 12%, mainly observed in those patients receiving intravenously treatment. Osteonecrosis of the jaws associated to oral bisphosphonate,…

medicine.medical_specialtyOsteoporosisOdontologíaReviewBone resorptionBone remodelingOsteoclastmedicineHumansIn patientGeneral DentistryPathologicalOral Medicine and PathologyAlendronateBone Density Conservation Agentsbusiness.industryNecrotic bonemedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgerymedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryBisphosphonate-Associated Osteonecrosis of the JawComplicationbusiness
researchProduct